NEW YORK (GenomeWeb News) – Of the 33 firms that are included in the GenomeWeb Daily News Index of life science tools and molecular diagnostics makers, eight of those had stock price gains exceeding 100 percent for full-year 2009.

As was the case with tech stocks in general in the market, many of the firms in the Index had double-digit returns, with only six firms having a drop in their stock price compared to the close of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.